Patents by Inventor Anne Armstrong

Anne Armstrong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7220777
    Abstract: The invention provides compounds of formula (I) a salt, or solvate thereof.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: May 22, 2007
    Assignee: SmithKline Beecham P.L.C.
    Inventors: Sula Anne Armstrong, Dieter Wolfgang Hamprecht, Martin Jones, David Richard Witty, Kamal A Al-Barazanji, Mohammad Tadayyon
  • Publication number: 20050064911
    Abstract: A user interface (UI) for use with a secondary display module of a mobile electronic device. The UI allows the user to access application data without activating the operating system (OS) of the main portion of the mobile electronic device. The UI can allow the user to access application data by activating the OS and an associated low-power application without launching the application. The UI also provides a simple mechanism to disable wireless components of the mobile electronic device while allowing the user to use other non-wireless components. The secondary display module can be detached from a main portion of the mobile electronic device, with the UI being automatically activated. The UI can be automatically activated (or deactivated) in response to deactivation (or activation) of the UI of the main display of the mobile electronic device.
    Type: Application
    Filed: June 17, 2004
    Publication date: March 24, 2005
    Applicant: Vulcan Portals, Inc.
    Inventors: Chao-Chi Chen, Martin Kee, Craig O'Connell, Anne Armstrong, Stephen Perrin
  • Publication number: 20030013675
    Abstract: A combination of therapeutic agents useful in the treatment of obstructive airways and other inflammatory diseases comprising (i) an adenosine A2A receptor agonist; and (ii) an anti-cholinergic agent, preferably comprising a member selected from the group consisting of tiotropium and derivatives thereof; the combination being therapeutically effective in the treatment of the diseases when administered by inhalation; as well as to a method of treating the obstructive airways and other inflammatory diseases comprising administering separately, simultaneously or sequentially to the mammal by inhalation a therapeutically effective amount of the combination of therapeutic agents; as well as to a pharmaceutical composition comprising a pharmaceutically acceptable carrier together with the combination of therapeutic agents; as well as to a product containing the compounds of the combination for separate, simultaneous or sequential administration by inhalation to a mammal for the treatment of obstructive airways and
    Type: Application
    Filed: May 24, 2002
    Publication date: January 16, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Michael Yeadon, John W. Watson, Roison Anne Armstrong
  • Patent number: D855801
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: August 6, 2019
    Assignee: Rehabilitation Institute of Chicago
    Inventors: Christopher Connolly, Anne Armstrong, Randall Orians, Steve Austin